Full Text:  <702>

CLC number: Q354

On-line Access: 

Received: 2005-11-22

Revision Accepted: 2005-12-26

Crosschecked: 0000-00-00

Cited: 0

Clicked: 2124

Citations:  Bibtex RefMan EndNOte GB/T7714

-   Go to

Article info.
1. Reference List
Open peer comments

Journal of Zhejiang University SCIENCE B 2006 Vol.7 No.2 P.164~164

doi: 10.1631/jzus.2006.B0164


Human cancer genetics


Author(s):  Li Marilyn, Albertson Donna

Affiliation(s):  1.Medical School, Tulane University, New Orleans, LA 70112-2699, USA; Cancer Research Institute, University of California, San Francisco, California 94143, USA

Corresponding email(s):  mli2@tulane.edu , albertson@cc.ucsf.edu

Key Words:  Cancer genetics, Oncogenes, Tumor suppress genes, Microarray CGH (comparative genomic hybridization), Presymptomatic testing


Share this article to? More

Li Marilyn, Albertson Donna. Human cancer genetics[J]. Journal of Zhejiang University Science B, 2006, 16(7): 164~164.

@article{0
title="Human cancer genetics",
author="Li Marilyn, Albertson Donna",
journal="Journal of Zhejiang University Science B",
volume="7",
number="16",
pages="164~164",
year="2006",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.2006.B0164"
}

%0 Journal Article
%T Human cancer genetics
%A Li Marilyn
%A Albertson Donna
%J Journal of Zhejiang University SCIENCE B
%V 7
%N 16
%P 164~164
%@ 1673-565X
%D 2006
%I Zhejiang University Press & Springer

TY - JOUR
T1 - Human cancer genetics
A1 - Li Marilyn
A1 - Albertson Donna
J0 - Journal of Zhejiang University Science B
VL - 7
IS - 16
SP - 0
EP - 0
SN - 1673-565X
Y1 - 2006
PB - Zhejiang University Press & Springer
ER -


Abstract: 
The short report will be focused on the genetic basis and possible mechanisms of tumorigenesis, common types of cancer, the importance of genetic diagnosis of cancer, and the methodology of cancer genetic diagnosis. They will also review presymptomatic testing of hereditary cancers, and the application of expression profiling to identify patients likely to benefit from particular therapeutic approaches.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference

[1] Jiang, G.C., Young, F., Li, M., Weissbecker, K., Price, S., Kim, K.C., Rice, J., La Russa, V.F., Safah, H., Ehrlich, M., 2003. Imtinib (STI571) provides only limited selectivity for CML cells and treatment might be complicated by silent SCR/ABL genes. Cancer Biology & Therapy, 2(1):166/1-166/7.

[2] Kops, G.J., Weaver, B.A., Cleveland, D.W., 2005. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer, 5(10):773-785.

[3] Pinkel, D., Albertson, D.G., 2005. Array comparative genomic hybridization and its applications in cancer. Nat. Genet., 37(Suppl 6):S11-S17.

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952276; Fax: +86-571-87952331; E-mail: jzus@zju.edu.cn
Copyright © 2000~ Journal of Zhejiang University-SCIENCE